Advertisement
Advertisement
TOPIC

National Medical Products Administration (China)

National Medical Products Administration (China)
The latest news and top stories on National Medical Products Administration. A prominent Beijing, China-based governmental regulatory agency, the National Medical Products Administration (NMPA) is dedicated to safeguarding public health by regulating drugs, medical devices, and cosmetics. Its primary mission involves ensuring the safety and efficacy of these products through comprehensive approval, registration, and post-market supervision. The NMPA’s main areas of activity include setting standards, conducting inspections, and managing adverse event monitoring.
China’s private sector

China’s biotech boom: record 5,215 clinical drug trials reported in 2025

Cancer treatments remain the top research focus as Beijing’s drive to make biotech a strategic industry draws attention in Washington.

The next tech war? Why biotech may become a new US-China battleground

China’s biotech boom drives surge in home-grown innovative drug approvals

Domestic firms dominate China’s drug approvals amid jump in spending and out-licensing deals as regulator speeds path to market.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement